Patients
A great team dedicated to your health
Your health is a priority. That is why we offer you the revolution of personalised medicine. We have more than 850 professionals who work in a network supported by the latest technology and who will focus on you to offer you innovation, experience, and closeness.
Present in 7 countries
+16k
patients seen in medical oncology
3
radiation oncology units
+20
years of experience
Telemedicine
Wherever you are. We the bridge distance to speed up our patient care. Our telemedicine platform gives you access to the best professionals without the need to travel, quickly and reliably. Access online and receive more personalised treatment, a specialised diagnosis, preventive consultations, and rigorous follow-ups.
Genetic diagnostics
Genetic diagnostics
Diagnostic imaging
Genetic diagnostics
Your DNA hides the keys to your future; we help you decipher them. We are pioneers in prevention and diagnostics with advanced genetic techniques. Make the right decisions based on your genes.
About usDiagnostic imaging
Trust in the precision and experience of an accessible medical team. We offer you the full range of medical imaging tests with the best technology.
About us- Genetic diagnostics
- Diagnostic imaging
Second
opinion
Cherish your peace of mind. Thanks to our networking and our extensive medical and academic activity, more and more patients come to us to guarantee their confidence in the diagnosis and treatment they receive.
Related press releases
Press room-
14/11/2025
Atrys reaffirms its positive performance and grows by 8.2%, driven by the expansion of its oncology division in Spain and Mexico
Atrys, a global healthtech company providing precision medical diagnosis and treatment services, a leader in telemedicine and cancer treatment, has announced its results for the third quarter of…
-
11/11/2025
The UB-Atrys Chair presents awards for the three best research projects in personalised radiotherapy
The UB-Atrys Chair in Personalised Radiotherapy, promoted by Atrys Health and the University of Barcelona, has presented awards to the three best scientific publications of the year in the field of…
-
05/11/2025
Atrys agrees to sell Aspy to Grupo Echevarne for €145 million and refocuses its strategy on areas with greater growth potential
Atrys Health has signed a share purchase agreement to transfer 100% of Aspy Global Services S.A.U. (ASPY) to Grupo Echevarne, S.L. for €145 million. The agreement also provides for contingent…
Would you like to get in touch with us?
Tell us how we can help you